medical devices and innovations

Roche will configure the LightCycler and MagNA Pure systems before local laboratory technicians receive training and deploy the equipment to Bunia for validation testing.

D-dimer testing measures fragments produced when blood clots break down and can help assess patients with increased clotting activity.

The development of Accela and NeoArc involved collaboration with an advisory group comprising several cancer research and treatment institutions.

The CE-IVDR-certified test is designed to detect three diabetes-associated autoantibodies (AAbs) that can indicate an increased risk of developing T1D.

Anaconda is targeting the large vessel occlusion stroke market, where mechanical thrombectomy is used to remove blood clots from blocked cerebral arteries.

The ACUVUE OASYS MAX 2 Week lens is part of the wider ACUVUE OASYS MAX portfolio, which J&J developed to provide advanced options for people who use reusable contact lenses.

HAKIKA responds to concerns raised by public, private and faith-based healthcare providers over tariffs, claims processing, payment delays, pre-authorization, system reliability and empanelment.

Launched at the World Health Assembly in 2025, Aira addresses three challenges facing primary healthcare: staff shortages, inconsistent use of clinical guidelines and the administrative workload that limits the time health workers spend with patients.

The Photon Counting Sensor Fab is the only facility of its kind in Europe and will produce semiconductor sensors used in advanced X-ray imaging.

The acquisition brings MLM’s laboratory infrastructure and scientific expertise into Labcorp’s global network, creating a broader platform to support clinical trials across multiple regions.